blog background

MMI Selected as Imaging Core Lab for Pivotal Shoulder Study

October 01, 2012
Copied to clipboard
MMI developed the image acquisition and analysis protocols which were submitted to and approved by the FDA.

Medical Metrics, Inc. (MMI), an experienced provider of medical imaging core lab services for global clinical trials, has been selected to conduct an independent evaluation of medical images as part of an FDA Investigational Device Exemption (IDE) clinical trial of a unique shoulder prosthesis. The new device represents an advance over existing implants because it preserves bone stock and allows for future revisions. The successful completion of this study will expand the sponsor’s current presence in the third largest joint reconstruction segment.

MMI developed the image acquisition and analysis protocols which were submitted to and approved by the FDA. These protocols included the image acquisition methods and required assessment panels necessary to evaluate treatment performance such as device fixation and integrity. During the trial, MMI will providecomprehensive image analysis and management of radiographic data.

MMI’s scientific staff and physician consultants specialize in joint replacement studies and the current client list includes global leaders in joint arthroplasty. Tom Martin, MMI’s CEO commented “Our commitment to provide the highest level of scientific expertise and project management support is why sponsors trust MMI with their pivotal trials. We are honored that we were chosen by this market leader as the imaging core lab for this important study.”

About Medical Metrics

Medical Metrics, Inc. (MMI) is an experienced, ISO 9001-certified, independent imaging core lab for multi-center clinical trials. Since 2000, MMI has partnered with clinical trial sponsors to conduct comprehensive imaging evaluations of treatments for musculoskeletal, cardiovascular, and neurological disorders. Trials range from pre-clinical and early-phase clinical studies to pivotal trials and post-approval surveillance. With an ISO-certified quality system, experienced project management team, proprietary data management platform, and luminary group of radiology and cardiology thought-leaders, MMI is uniquely positioned to deliver high-quality imaging core lab services for complex clinical trials.

Latest MMI News & Events

MMI Investigates Spinal Instability Using the Sagittal Plane Shear Index (SPSI)
In a research letter in Spine, MMI collaborated with researchers to investigate the SPSI as an objective measure of instability in lumbar stenosis patients with degenerative spondylolisthesis.
Dr. John Hipp Receives NASS Henry Farfan Award
MMI co-founder, Dr. John Hipp, was recognized for his outstanding contributions to spine basic research.
MMI's QMA® software increases accuracy in cervical disc replacement trial
A recent study took advantage of Medical Metrics state-of-the-art Quantitative Motion Analysis, or QMA®, software to track the motion of cervical disk replacements with extreme precision.